“…We have shown that rtPA can be used safely, even in patients with recent bleeding, as long as there is no evidence of active bleeding during the treatment period. However, during treatment, we have to pay special attention not to miss the bleeding complication, which sometimes can be life threatening, such as central nervous system, gastrointestinal, or hepatic hemorrhage, as reported in the case of use in myocardial infarction (13)(14)(15). Accordingly, patients receiving rtPA treatment should be monitored closely for signs of bleeding to promptly institute intervention when necessary.…”